新城疫病毒或禽偏肺病毒活疫苗与经典及变异株传染性支气管炎病毒疫苗联合接种一日龄肉鸡的保护性免疫比较
研究在一日龄母源抗体阳性商品肉鸡中同时接种新城疫病毒或禽偏肺病毒B亚型活疫苗与H120及CR88传染性支气管炎病毒活疫苗。两项实验显示,传染性支气管炎病毒疫苗接种组纤毛保护率维持在90%以上,禽偏肺病毒攻击保护未受损害,新城疫病毒血凝抑制平均滴度保持在保护滴度以上(>3 log2)。同时接种不干扰对新城疫病毒、传染性支气管炎病毒或禽偏肺病毒的保护。
要点
- 两项实验中传染性支气管炎病毒疫苗接种组气管纤毛保护率均维持在90%以上。
- 禽偏肺病毒、H120和CR88同时接种时,对禽偏肺病毒强毒攻击的保护未受损害。
- 新城疫病毒单苗和联合接种组血凝抑制平均滴度均保持在保护滴度以上(>3 log2)。
核心结论
- 两项实验表明,新城疫病毒VG/GA-Avinew或禽偏肺病毒B亚型活疫苗与H120和CR88疫苗同时接种不干扰对新城疫病毒、传染性支气管炎病毒或禽偏肺病毒的保护。
研究设计与样本
- 在一日龄母源抗体阳性商品肉鸡中同时接种新城疫病毒或禽偏肺病毒B亚型活疫苗与H120及CR88传染性支气管炎病毒活疫苗。
- 第一项实验分四组:一组不接种,三组分别接种新城疫病毒VG/GA-Avinew、H120+CR88或VG/GA-Avinew+H120+CR88。
- 第二项实验以禽偏肺病毒B亚型活疫苗替代新城疫病毒。
- 每日监测临床症状,定期采集口咽拭子检测疫苗病毒,接种后21天采血做血清学检测。
- 每组10只鸡分别用M41、QX或禽偏肺病毒B亚型强毒株攻击。
主要发现
- 两项实验中传染性支气管炎病毒疫苗接种组气管纤毛保护率均维持在90%以上。
- 禽偏肺病毒、H120和CR88同时接种时,对禽偏肺病毒强毒攻击的保护未受损害。
- 新城疫病毒单苗和联合接种组血凝抑制平均滴度均保持在保护滴度以上(>3 log2)。
关键数值与推荐
- 传染性支气管炎病毒攻击后5天评估气管纤毛保护。
- 禽偏肺病毒攻击后观察临床症状评分至10天。
- 新城疫病毒以血凝抑制抗体滴度作为保护性免疫指标,保护滴度为>3 log2。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This study reports on the simultaneous administration of live NDV or aMPV subtype B vaccines alongside two live IBV (Massachusetts-H120 and 793B-CR88) vaccines in day-old maternal-antibody positive commercial broiler chicks. In the first experiment, chicks were divided into four groups; one unvaccinated and three groups vaccinated with live NDV VG/GA-Avinew, live H120 + CR88, or VG/GA-Avinew + H120 + CR88. In the second experiment, live aMPV subtype B vaccine was used in place of NDV. Clinical signs were monitored daily and oropharyngeal swabs were taken at regular intervals for vaccine virus detection. Blood was collected at 21 dpv for serology. 10 chicks from each group were challenged with virulent strains of M41 or QX or aMPV subtype B. For IBV, after 5 days post challenge (dpc), tracheal ciliary protection was assessed. For aMPV, clinical scores were recorded up to 10 dpc. For NDV, haemagglutination inhibition (HI) antibody titres were assayed as an indicator of protective immunity. In both experiments, ciliary protection for IBV vaccinated groups was maintained above 90%. The protection against virulent aMPV challenge was not compromised when aMPV, H120 and CR88 were co-administered. NDV HI mean titres in single and combined NDV-vaccinated groups remained above the protective titre (>3 log2). Both experiments demonstrated that simultaneous administration of live NDV VG/GA-Avinew or aMPV subtype B alongside H120 and CR88 vaccines does not interfere with protection conferred against NDV, IBV or aMPV.
引用
- Ball C, Forrester A, Herrmann A, et al. Comparative protective immunity provided by live vaccines of Newcastle disease virus or avian metapneumovirus when co-administered alongside classical and variant strains of infectious bronchitis virus in day-old broiler chicks. Vaccine. 2019. PMID: 31607602. doi:10.1016/j.vaccine.2019.09.081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。